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~t-Bungarotoxin (ctBgt) was shown to inhibit the binding of the ~2SI-labeled substance P (SP) and eledoisin (EL) to the 
rat brain membranes with K~ values of 8.0 + 5.0 x 10 -8 and 1.1 +0.5 x 10 -~ M, respectively. Lower inhibitory activity 
was manifested by several other postsynaptically acting snake venom neurotoxins. The ~tBgt inhibition of SP binding 
with a K~ value of 8.5 + 5.5 x 10 -a M to solubilized preparations of the rat brain membranes was demonstrated. The 
capacity to displace SP was found for d-tubocurarine and phencyclidine, although at concentrations considerably higher 
than those affecting the nicotinic acetylcholine r ceptors (AChRs). The results obtained suggest that some of the ~tBgt- 
binding polypeptides, distinct from neuronal AChRs, may be functionally associated with the tachykinin receptors 
(TchR). 
~t-Bungarotoxin; Substance P; Tachykinin receptor; (Rat brain membrane) 
1. INTRODUCTION 
Substance P, a peptide neurotransmitter, be- 
longs to the family of tachykinins that manifest a 
multitude of neuro- and immunomodulatory ac- 
tivities [1]. One of the reasons for this versatility 
may be their ability to interact not only with several 
types of TChRs, but also with the receptors of clas- 
sical neuromediators. For example, the effects of 
SP on AChRs were demonstrated in several labora- 
tories [2-5]. Taking these data into account, espe- 
cially the SP inhibition of crBgt binding to AChR 
[5], we addressed another problem: whether oeBgt 
and other AChR ligands can act on TChR. 
2. MATERIALS AND METHODS 
[12Sl]BH-SP and [125I]BH-EL were synthesized as in [6,7]. 
Their binding to rat brain membranes was analyzed as described 
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in [6] for the SP derivative, for the radioactive EL a longer in- 
cubation time (50 min) was used. 
When studying inhibitory activity, oeBgt (Boehringer Mann- 
heim) as well as other neurotoxins and cytotoxins were prein- 
cubated with rat brain membranes at 20°C for 60 min followed 
by addition of radioactive tachykinins. All other low molecular 
weight ligands were added simultaneously with [~zSI]BH-SP and 
incubated for 45 min. 
To analyze the binding to the solubilized TChR, rat brain 
membranes were treated with CHAPS essentially as in [8]. 
[t251]BH-SP was incubated at 0°C for 2 h with 200/A of 
solubilized membranes (3 mg protein/ml) in 50 mM Tris-HCI 
buffer, pH 7.4, containing 0.5°70 CHAPS, 50 mM NaC1, 3 mM 
MgCI2, 1°/0 bovine serum albumin, leupeptin (4 /zg/ml), 
bacitracin (40/~g/ml) and phenylmethylsulfonyl fluoride (8.5 
/~g/ml) in the presence or absence of ceBgt. Nonspecific binding 
was determined in the presence of 1/zM SP. Unbound radioac- 
tive ligands were removed from the solubilized preparations u - 
ing Whatman GF/B filters as in [8]. The sources of ligands, as 
well as the references to the synthesis and purification of pep- 
tides and neurotoxins are given in more detail in [7]. 
3. RESULTS AND DISCUSSION 
As can be seen from fig. 1, preincubation of rat 
brain membranes with ceBgt inhibits the specific 
binding of [125I]BH-SP, a ligand with the highest 
affinity for an NK-1 type TChR (see [9] for recep- 
tor classification). The K~ value of 8.05 + 5.0 x 
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Fig.l. t~Bgt inhibition of [~zSI]BH-SP (0.2 nM, curve 1)and 
[~25I]BH-EL (0.25 nM, curve 2) binding to rat brain membranes 
(~ 2.5 mg protein/ml). Each point in the plot is an average of 
duplicate or triplicate measurements. K~ values and error limits, 
8.05 + 5.0 x 10 -8 M and 1.1 + 0.5 × 10 -6 M for SP and EL 
derivatives, respectively, were calculated from IC5o values. The 
latter were determined with different batches of radioactive 
ligands and membranes u ing for SP and EL derivatives the Ka 
values of 0.7 and 0.4 nM, respectively, found from the Scat- 
chard plots (not shown). 
10 -s  M differs by almost 3 orders of magnitude 
from the KI value of 1.2 x 10- 5 M characterizing 
the effect of SP on the interaction of radioactive 
aBgt with the AChR from the Torpedo electric 
organ [5]. In other words, the ctBgt affinity for the 
NK-1 TChR is much higher than that of SP for 
AChR. 
The effect of oeBgt is virtually irreversible, since 
after preincubating the membranes with ~Bgt fol- 
lowed by repeated washings and 24-72 h incuba- 
tion in an appropriate buffer at 0°C no [125I]BH- 
SP binding could be observed. In control experi- 
ments, the membranes that underwent he same 
treatment, except for the addition of ceBgt, effi- 
ciently bound the radioactive SP. 
We also examined the trBgt effect on an NK-3 
TChR whose preferable ligands are neurokinin B 
and BH-EL [9,10]. The higher value of KI 
(1.1 +_ 0.5 x 10 -6 M (see curve 2 in fig.l)) in- 
dicates that the c~Bgt affinity for the NK-3 receptor 
is lower than for the NK-1 type. This finding cor- 
relates with the less pronounced effect of EL, as 
compared with SP, on the AChR [4]. 
Treatment with CHAPS diminished the capacity 
to bind [125I]BH-SP: for solubilized preparations 
the binding parameters were Kd=9.0 _+ 6.0 nM 
and Bmax = 18 _+ 12 fmol /mg protein (the binding 
100 - 
~80-  .c 
.c 60 .Q 
~o 
20 
i i i 
6 7 8 
-Ig[ctBgt], (MJ 
Fig.2. ~Bgt inhibition of [~25I]BH-SP (0.7 nM) interaction with 
the CHAPS-solubilized rat brain membranes, 
K1=8.5 + 5.5 x 10 -s M. 
curve is not shown), as compared with 0.7 + 0.05 
nM and 60 + 10 fmol /mg protein for the intact rat 
brain membranes [6]. However, the potency of 
ceBgt to compete with [~25I]BH-SP was largely 
preserved on solubilization (fig.2), the KI value be- 
ing 8.5 _+ 5.5 x 10-s M. This result suggests that 
trBgt either directly interacts with the rat brain 
TChR or binds to a component tightly associated 
with it. Noteworthy, SP competed with radioactive 
ceBgt for the binding centers on the solubilized 
Torpedo AChR [5]. 
In order to characterize in more detail the 
SPAeBgt-binding sites in the rat brain, we studied 
the inhibitory activity of different snake venom 
neurotoxins of the so-called long-chain and short- 
chain types (see classification i [11 ]). Complete in- 
hibition of [~25I]BH-SP binding could be achieved 
with the long-type toxin 3 Naja naja siamensis 
(table 1, fig.3). However, its KI (1.1 _+ 0.4 x 10 -6  
M) characterizes a lower potency than that of oeBgt. 
(Interestingly, trBgt and toxin 3 are virtually 
equipotent when interacting with the oeBgt-binding 
sites of the rat brain [12].) 
Among a series of short-chain eurotoxins, only 
one (Naja mossambica mossambica) exerted a 
marked effect at 10 -5 M. As shown in table 1 for 
neurotoxin II Naja naja oxiana, the inhibition 
becomes quite efficient at 10 -4  M. However, at 
such a concentration the effect might be, to a large 
extent, associated with perturbations of membrane 
structure, since the snake venom cytotoxins, mem- 
brane active polypeptides [11], are even more effi- 
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Table 1 
Inhibition of [~25I]BH-SP binding to the rat brain membranes by different AChR ligands 
Ligand Concentration Q~M) Inhibition (%) 
Long-chain neurotoxins 
~Bgt 5.0 10(P 
toxin 3 Naja naja siamensis 28.0 100 
neurotoxin I Naja naja oxiana 56.0 0 
Short-chain eurotoxins 
toxin 3 Naja mossambic mossambica 22.0 20 
t~-toxin Naja nigricollis 17.0 ~< 5
erabutoxin a Laticauda semifasciata 25.0 ~< 5
neurotoxin II Naja naja oxiana 12.0 ~<5 
100.0 75 
conotoxin GI 250 0 
thymopentin 250 0 
Carbamoylcholine 1000 0 
Nicotine 1000 ~< 5
Cytisine 1000 ~< 5
d-Tubocurarine 20.0 15 
300 50 
Phencyclidine 10.0 15 
500 50 
Cytotoxins I and lI Naja naja oxiana b 100 100 
"Concentration f radioactive ligand was 0.2 nM in all experiments, inhibition by 
SP taken as being 100% 
bgiven for comparison (these compounds are not AChR ligands) 
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cient at similar concentrat ions (table 1, fig.3). 
Therefore,  the interact ion of  snake venom neu- 
rotoxins with the rat brain NK-1 TChR is specific 
and strongly dependent on the structural  features 
o f  a part icular  neurotoxin.  
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Fig.3. Inhibition of [125I]BH-SP binding (0.25 nM) to rat brain 
membranes by toxin 3 Naja naja siamensis (curve 1), 
Kl= 1.1 + 0.4 x 10 -6 M, and cytotoxin II Naja naja oxiana 
(curve 2), KI = 1.0 + 0.3 x 10 - 6 M. [C], molar concentration f 
toxins. 
Besides neurotoxins,  we have also examined the 
inf luence of  other AChR l igands on the SP binding 
(table 1). Carbamoylcho l ine at 1 mM failed to com- 
pete with [125I]BH-SP. The presence of  this agonist 
d id not  abol ish the inhibitory effect o f  ctBgt on the 
TChR.  Nicotine, known to act on dif ferent AChRs  
[13] exerted pract ical ly no effect on the SP binding. 
Cytisine, one of  the neuronal  AChR l igands, was 
also ineffective. On the other hand, d- tubocurar-  
ine, an antagonist ,  and a non-competi t ive blocker,  
phencycl idine, displaced [~25I]BH-SP in a con- 
centrat ion-dependent  manner.  However,  in both 
cases the effective concentrat ions were at least 2 
orders o f  magnitude higher than those affecting 
di f ferent kinds of  AChRs  [14,15]. 
It has been demonstrated that cr-conotoxins 
f rom f ish-hunting cone snails [16] and 
thymopoiet in  [17] compete with crBgt for the 
Torpedo AChR.  With  this in mind,  we tested the 
capacity of  conotoxin  G 1 and thymopent in ,  the ac- 
tive f ragment o f  thymopoiet in ,  to inhibit  associa- 
t ion o f  [125I]BH-SP with the rat bra in  membranes.  
The two peptides at 250/~M proved inactive. Sum- 
mariz ing the data  of  table 1, it can be concluded 
that the SP/crBgt-binding sites appear  to differ 
113 
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from the functional AChRs and display the 
preference towards distinct snake venom neurotox- 
ins as compared to other tested AChR ligands. 
It should be mentioned that binding of  oeBgt is 
not a property inherent in all types of  nicotinic 
AChRs.  For example, such an activity is mani- 
fested by receptors form Torpedo electroplaque 
[11,13], mammalian muscles [18], chick optic lobe 
[19], as well as by neuronal AChRs from 
Drosophila [15], locust [20] and goldfish brain 
[21]. In contrast, the neuronal AChRs from the 
clonal cell line PC12 [22], human and bovine [23] 
or rat brain [18] do not interact with o~Bgt. 
Mammalian and avian brain also contain pro- 
teins that differ in their affinity for ceBgt from 
10 -7 to 10 -9 M, are not functional AChRs and 
have an obscure role [12,24]. Our data on the ceBgt 
inhibition of  [125I]BH-SP binding with a KI value 
of  the order of  10-7 _ 10-8 indicate that at least 
some of  these proteins are identical to the 
SP/ceBgt-binding sites described in the present 
communicat ion and therefore might be implicated 
in mediating physiological responses to SP. 
The sites involved in ceBgt binding have been 
identified in the amino acid sequence of  the 
Torpedo AChR ce-subunit (see, for example, [25]). 
We could not find sequences homologous to those 
sites in the substance K receptor from bovine 
stomach [26], the only sequenced receptor of  the 
TChR family. The computer analysis failed to 
detect extended homologies between his receptor 
and Torpedo, muscle, or neuronal AChRs (See [7] 
for details). 
The primary structures of  acetylcholine-insensi- 
tive oeBgt-binding proteins from the rat brain are 
not yet known. However, one of  them was recently 
demonstrated to consist of  subunits similar to the 
oe, ~', 9' and d~ subunits of  the Torpedo AChR [27]. 
There are many reasons to believe that these aBgt- 
binding polypeptides hould be related to other 
AChR-gene derived proteins. 
At present it is not clear whether c~Bgt binding is 
due to a polypeptide that is attached to TChR so 
tightly that it cannot dissociate in detergent, or 
o~Bgt interacts with a site on the TChR itself. The 
latter possibility seems more attractive and implies 
that, in contrast to the lack of  homology in the 
primary structures, the spatial organization of  the 
ligand-binding sites should be similar in different 
proteins interacting with trBgt. This feature may be 
a link between two types of  receptor families: 
l igand-gated ion channels represented by AChR,  
and G-protein-dependent systems comprising 
TChR.  The same situation can be anticipated for 
the acetylcholine-binding sites in the sequentially 
unrelated nicotinic AChRs and muscarinic AChRs,  
the latter belonging to the same superfamily as 
TChR [26]. 
To summarize, our experimental results demon- 
strate that, firstly, neuronal TChRs may be respon- 
sive both to their own and AChR ligands, and, 
secondly, the functional role o f  some brain 
acetylcholine-insensitive crBgt-binding polypep- 
tides is associated with that of  TChR. 
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